1. Home
  2. GEVO vs FDMT Comparison

GEVO vs FDMT Comparison

Compare GEVO & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gevo Inc.

GEVO

Gevo Inc.

HOLD

Current Price

$1.91

Market Cap

453.1M

Sector

Industrials

ML Signal

HOLD

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

HOLD

Current Price

$9.33

Market Cap

513.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEVO
FDMT
Founded
2005
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
453.1M
513.6M
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
GEVO
FDMT
Price
$1.91
$9.33
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$6.42
$34.13
AVG Volume (30 Days)
2.0M
690.4K
Earning Date
01-01-0001
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$711,000.00
$37,000.00
Revenue This Year
$913.54
$21,227.03
Revenue Next Year
$9.75
$161.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$2.24
52 Week High
$2.95
$12.34

Technical Indicators

Market Signals
Indicator
GEVO
FDMT
Relative Strength Index (RSI) 50.84 52.33
Support Level $1.56 $8.88
Resistance Level $2.14 $9.78
Average True Range (ATR) 0.08 0.53
MACD 0.01 0.00
Stochastic Oscillator 88.24 33.53

Price Performance

Historical Comparison
GEVO
FDMT

About GEVO Gevo Inc.

Gevo Inc is a next-generation diversified energy company committed to fueling America's future with cost-effective, drop-in fuels that contribute to energy security, abate carbon, and strengthen rural communities to drive economic growth. Its technology can be used to make a variety of renewable products, including sustainable aviation fuel (SAF), motor fuels, chemicals, and other materials that provide U.S.-made solutions. The business model includes developing, financing, and operating production facilities that create jobs and revitalize communities. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: